American clinical stage biopharmaceutical company at Boulder in Colorado, founded in 2017 and listed on the Nasdaq, which develops small molecule medicines for muscle diseases. Works on treatments for Duchenne and Becker muscular dystrophy and for cardiac muscle disease including hypertrophic cardiomyopathy, running its own discovery chemistry and muscle biology research and clinical trials of its candidate drugs.
Aucun commentaire disponible.
Laissez votre note & commentaire